Masimo Corporation
NASDAQ:MASIMedical - Devices
+$0.00 today
- Market cap
- $9.42B
- Beta
- 1.10
- P/E (TTM)
- 123.1
- EPS (TTM)
- $1.46
Volume 0.00M
Average 1.08M
MASI Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
Masimo CorporationNASDAQ: MASI
Net Debt · Q1 FY2026 · quarter ended Apr 2026
Net debt falls 34.4% from a year ago
Net debt stood at $361.3M at the end of Q1 FY2026, down 34.4% from a year earlier and down 11.2% from the prior quarter. Over 3 fiscal years it compounded at -21.0% a year.
Context
- Net debt amounted to 22.0% of total assets at the end of Q1 FY2026, down 2.0 pp from a year earlier.
- Net debt increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net debt keeps falling in the next quarterly balance sheet after a -34.4% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Debt history
USD · from the balance sheet
- Latest · FY2025
- 407M USD
- Year-over-year change
- -39.1%
| Period | Period end | Net Debt | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 407M | -39.1% |
| FY2024 | 2024-12-28 | 668.5M | -17.2% |
| FY2023 | 2023-12-31 | 807M | -2.3% |
| FY2022 | 2022-12-31 | 825.9M | +215.9% |
| FY2021 | 2021-12-31 | (712.6M) | — |
Net Debt vs competitors
How MASI compares with its peers on the latest reported figures
- Peers report in different currencies, so net debt is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of -34.4% is the 9th highest of 11, against a peer median of +3.5%.
- Net debt amounts to 22.0% of total assets for MASI, versus a peer median of 19.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $7.52B USD | -6.5% | -19.6% | 38.0% | |
| Jun 2026 | $3.66B USD | +13.8% | +36.8% | 32.1% | |
| Jun 2026 | $3.39B USD | -10.6% | -15.4% | 29.2% | |
| Jun 2026 | $1.24B USD | +26.9% | +1.5% | 24.1% | |
| Jun 2026 | $686.7M USD | -33.8% | +1.6% | 6.7% | |
| Jun 2026 | €364.35M EUR | +13.6% | — | 13.9% | |
| Apr 2026 | $361.3M USD | -34.4% | -21.0% | 22.0% | |
| Jun 2026 | $84.16M USD | +469.3% | — | 2.9% | |
| Sep 2026 | -$36.47M USD | +23.9% | — | 8.2% | |
| Jun 2026 | -€386.78M EUR | -1737.1% | — | 83.7% | |
| Sep 2026 | -$529M USD | -43.4% | — | 3.4% | |
| Peer median (excluding MASI) | — | +3.5% | +1.5% | 19.0% | |
Competitors are the stored peer set for MASI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 745.3M | 202.9M | 163M | 177.6M | 152.3M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 244.69M | 505.1M | 421M | 489.3M | 327.5M |
| Inventory | 201.4M | 501M | 545M | 459.2M | 380.3M |
| Other Current Assets | 6.7M | 6M | 10.5M | 24.4M | 3.9M |
| Total Current Assets | 1.24B | 1.31B | 1.23B | 1.23B | 926M |
| Property, Plant & Equipment (Net) | 303.3M | 472.1M | 483.5M | 456M | 355.1M |
| Goodwill | 100.3M | 445.4M | 407.7M | 96.7M | 101M |
| Intangible Assets | 72.5M | 722.6M | 652.3M | 558.2M | 52.1M |
| Long-term Investments | 13.8M | 13.8M | 9.9M | 8.6M | 71.3M |
| Tax Assets | 52.6M | 102.5M | 107.2M | 143.6M | 114.2M |
| Other Non-current Assets | 105.6M | 145.6M | 149M | 136.8M | 79.2M |
| Total Non-current Assets | 648.1M | 1.9B | 1.81B | 1.4B | 772.9M |
| Total Assets | 1.89B | 3.21B | 3.04B | 2.63B | 1.7B |
| Account Payables | 75.6M | 276.8M | 251.5M | 252.8M | 103M |
| Short-term Debt | 0 | 15.1M | 34.3M | 37.3M | 6.3M |
| Tax Payables | 30.3M | 72.4M | 50.2M | 55.5M | 0 |
| Deferred Revenue | 29.9M | 36M | 37.4M | 46.8M | 38.5M |
| Other Current Liabilities | 75.5M | 95.4M | 69.3M | 93.2M | 88.4M |
| Total Current Liabilities | 267.7M | 630M | 563.8M | 617.7M | 371.6M |
| Long-term Debt | 0 | 941.6M | 871.7M | 727.9M | 518M |
| Deferred Tax Liabilities | 5.1M | 163.6M | 111.7M | 100.1M | 26.4M |
| Deferred Revenue (Non-current) | 5.2M | 25M | 26.4M | 27.4M | 23M |
| Other Non-current Liabilities | 32.5M | 58.1M | 57.3M | 41.2M | 11.8M |
| Total Non-current Liabilities | 69.1M | 1.24B | 1.11B | 956.1M | 606.1M |
| Total Liabilities | 336.8M | 1.87B | 1.68B | 1.57B | 977.7M |
| Common Stock | 100K | 100K | 100K | 100K | 100K |
| Retained Earnings | 1.57B | 1.71B | 1.8B | 1.49B | 1.34B |
| Accumulated OCI | (5.5M) | 11.5M | (45.3M) | (108.2M) | (12.5M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.55B | 1.34B | 1.36B | 1.05B | 721.2M |
| Total Debt | 32.7M | 1.03B | 970M | 846.1M | 559.3M |
| Net Debt | (712.6M) | 825.9M | 807M | 668.5M | 407M |
Masimo Corporation
NASDAQ:MASI
Intrinsic Alpha fair value
Locked
Current Price
$179.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.